Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 01/12/25
Due: 01/12/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase I Study of BM2216 ER vs. Melogabalin Besilate: Safety, PK, and Food Effect in Healthy Adults | NCT06846567 | Zhejiang Anglikang Pharmaceutical Co., Ltd. | user2@example.com | None | 2024-12-01 | 2025-01-12 | 2026-01-12 | - | - | 2025-07-14 |